In this month’s TABJ, we are contemplating the power of conjoining passion and resources to achieve goals.

Alcon Labs South Africa exemplify a company who will not be overwhelmed by the magnitude of their cause—the treatment and prevention of glaucoma, a disease that statistically affects Africans in greater numbers than any other group. In this issue, we learn that Alcon will not let politics, economics or geography discourage them from providing world-class ophthalmology care to Africa. We also highlight Ranbaxy’s social causes, and how their pharmaceuticals are revolutionizing the patient care landscape.

We are also bringing to you this month analysis of a worthy cause being perverted by corruption. In “Reversal of Fortune”, TABJ highlights foreign aid. How effective is it, actually, and is the money reaching the people who most need it? Is the generosity of individuals and nations pooling resources being misplaced?

And, as always, TABJ has spoken to some of the best and brightest our industries have to offer—people whose passion have created great businesses that, by generating employment and sustainability, are shining examples of the power of business.

We hope you enjoy hearing from these people. As always, if you have anything you would like to see in TABJ, please join the conversation at sarak@georgemedia.ca.

Sara Kopamees